Medical Stocks To Watch Now – May 2nd

Eli Lilly and Company, UnitedHealth Group, Hims & Hers Health, Becton, Dickinson and Company, and Stryker are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks are shares of publicly traded companies involved in the development, manufacture or distribution of medical products and services—such as pharmaceuticals, biotechnology, medical devices and healthcare providers. Investors buy medical stocks to gain exposure to advances in healthcare innovation and the sector’s potential for growth. Their performance is often driven by factors like regulatory approvals, clinical trial outcomes and broader economic conditions. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of Eli Lilly and Company stock traded up $27.94 during midday trading on Friday, hitting $822.04. The company had a trading volume of 3,817,198 shares, compared to its average volume of 3,472,525. Eli Lilly and Company has a 1-year low of $677.09 and a 1-year high of $972.53. The business’s 50 day simple moving average is $826.90 and its two-hundred day simple moving average is $816.98. The stock has a market cap of $779.44 billion, a PE ratio of 70.08, a P/E/G ratio of 1.40 and a beta of 0.51. The company has a debt-to-equity ratio of 2.00, a current ratio of 1.15 and a quick ratio of 0.97.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Shares of NYSE UNH traded down $0.70 during mid-day trading on Friday, hitting $399.98. The company had a trading volume of 5,871,547 shares, compared to its average volume of 4,578,107. The business’s 50-day simple moving average is $497.29 and its 200-day simple moving average is $529.82. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group has a 12 month low of $393.31 and a 12 month high of $630.73. The firm has a market cap of $364.07 billion, a P/E ratio of 25.77, a PEG ratio of 1.37 and a beta of 0.61.

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

HIMS traded up $3.39 during trading on Friday, reaching $39.55. 28,669,920 shares of the company’s stock were exchanged, compared to its average volume of 16,661,939. The company has a market capitalization of $8.79 billion, a P/E ratio of 89.65 and a beta of 1.65. The business has a 50 day moving average price of $32.19 and a 200 day moving average price of $31.30. Hims & Hers Health has a fifty-two week low of $11.20 and a fifty-two week high of $72.98.

Becton, Dickinson and Company (BDX)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

Shares of Becton, Dickinson and Company stock traded down $1.62 during trading on Friday, hitting $167.92. 5,265,362 shares of the company’s stock traded hands, compared to its average volume of 1,797,444. Becton, Dickinson and Company has a twelve month low of $166.15 and a twelve month high of $251.99. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.13 and a quick ratio of 0.63. The company has a market cap of $48.22 billion, a PE ratio of 27.74, a PEG ratio of 1.63 and a beta of 0.35. The firm’s fifty day moving average price is $215.99 and its 200 day moving average price is $226.21.

Stryker (SYK)

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Shares of SYK traded up $3.35 during mid-day trading on Friday, reaching $377.34. The company had a trading volume of 2,250,349 shares, compared to its average volume of 1,602,559. The company’s 50-day moving average is $366.62 and its 200-day moving average is $373.60. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The company has a market capitalization of $144.03 billion, a P/E ratio of 48.63, a P/E/G ratio of 2.93 and a beta of 0.93. Stryker has a twelve month low of $314.93 and a twelve month high of $406.19.